A Real Time chemotherapy guidance tool

Rna Diagnostics is improving cancer chemotherapy management.
The RNA Disruption Assay™ (RDA™) provides physicians with an evaluation
of how patients are responding to chemotherapy. In real time.
If chemotherapy is working, the physician and patient can continue with confidence.
If chemotherapy is not working well enough, physicians may consider alternate therapies.
For patients, this means avoiding harmful side effects and an opportunity to improve outcomes.
This is personalized medicine.

Providing critical information to physicians
Improving the lives of women undergoing chemotherapy for breast cancer
Reducing healthcare costs

Enhancing breast cancer chemotherapy management.